Omeros Corp. (OMER)
8.69
-0.51
(-5.54%)
USD |
NASDAQ |
Dec 16, 13:41
Omeros Research and Development Expense (Quarterly): 15.76M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.693B |
| Eli Lilly & Co. | 3.466B |
| GeoVax Labs, Inc. | 5.044M |
| Vistagen Therapeutics, Inc. | 15.86M |
| Daré Bioscience, Inc. | 0.6933M |